The antiplatelet agent revacept prevents the increase of systemic thromboxane A2 biosynthesis and neointima hyperplasia
Abstract Neointima hyperplasia is a crucial component of restenosis after coronary angioplasty. We have hypothesized that enhanced generation of platelet-derived thromboxane (TX)A2 in response to vascular damage plays a critical role in neointimal hyperplasia and that antiplatelet agents may mitigat...
Guardado en:
Autores principales: | Sara Alberti, Qianqian Zhang, Ilaria D’Agostino, Annalisa Bruno, Stefania Tacconelli, Annalisa Contursi, Simone Guarnieri, Melania Dovizio, Lorenza Falcone, Patrizia Ballerini, Götz Münch, Ying Yu, Paola Patrignani |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e6a515e9c8494e3e985c043ce7cad9e0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Role of Thromboxane in the Course and Treatment of Ischemic Stroke: Review
por: Małgorzata Szczuko, et al.
Publicado: (2021) -
Uremia does not affect neointima formation in mice
por: Annemarie Aarup, et al.
Publicado: (2017) -
Inhibiting breast cancer by targeting the thromboxane A2 pathway
por: Haitao Li, et al.
Publicado: (2017) -
NLRC5 inhibits neointima formation following vascular injury and directly interacts with PPARγ
por: Peipei Luan, et al.
Publicado: (2019) -
Homer binds to Orai1 and TRPC channels in the neointima and regulates vascular smooth muscle cell migration and proliferation
por: Shuping Jia, et al.
Publicado: (2017)